Keyphrases
Sepsis
91%
Severe Sepsis
79%
Septic Shock
73%
COVID-19
73%
Intensive Care Unit
72%
Sepsis Shock
42%
Confidence Interval
40%
Community-acquired Pneumonia
35%
Critically Ill Patients
34%
Acute Respiratory Distress Syndrome
32%
Mechanical Ventilation
29%
Intensive Care Unit Admission
29%
Blood Culture
27%
Spain
27%
Septic Patients
27%
Mechanically Ventilated
26%
Acute Lung Injury
26%
Hospital Mortality
26%
Ventilator-associated Pneumonia
26%
Intensive Care Unit Mortality
24%
Organ Dysfunction
22%
COVID-19 Patients
22%
Patients with COVID-19
21%
Antibiotics
19%
Source Control
19%
Prospective Observational Study
19%
Randomized Controlled Trial
19%
Surviving Sepsis Campaign
18%
Multicenter Observational Study
17%
Differential Time to Positivity
17%
Drotrecogin Alfa
17%
Catheter-related Bloodstream Infection (CRBSI)
17%
Odds Ratio
17%
Procalcitonin
15%
Intensive Care Unit Patients
15%
Intubation
15%
28-day Mortality
15%
Empiric Antibiotics
14%
MR-proADM
14%
C-reactive Protein
14%
Critically Ill
14%
High Mortality
13%
Invasive Mechanical Ventilation
13%
Severe COVID-19
13%
Antibiotic Duration
13%
Catheter
13%
Bacterial Infection
12%
Hypoxemia
12%
Risk Factors
12%
Lactate
12%
Medicine and Dentistry
Sepsis
100%
Intensive Care Unit
95%
COVID-19
92%
Septic Shock
53%
Infection
44%
Artificial Respiration
41%
Acute Respiratory Distress Syndrome
41%
Cohort Analysis
27%
Acute Lung Injury
26%
Observational Study
25%
Antibiotic Therapy
25%
Ventilator-Associated Pneumonia
20%
Intensive Care
20%
Biological Marker
19%
Hemadsorption
17%
Cytokine
17%
Intensive Care Medicine
17%
Hospital Mortality
17%
Shock (Circulatory)
15%
Intubation
15%
Diagnosis
14%
Lung
13%
Drotrecogin Alfa
12%
Endotoxin
11%
C Reactive Protein
10%
Procalcitonin
10%
Pathophysiology
10%
Resuscitation
10%
Prognostic Factor
10%
Gram-Negative Bacteria
10%
SOFA Score
10%
Treatment Duration
10%
Diseases
10%
Prospective Study
10%
Randomized Controlled Trial
10%
Mixed Infection
10%
Polymyxin B
10%
Coronavirinae
9%
Retrospective Study
9%
Pseudomonas aeruginosa
9%
Klebsiella pneumoniae
9%
Comorbidity
9%
Oxygen Therapy
9%
Blood Culture
8%
Systemic Candidiasis
8%
Lower Respiratory Tract Infection
8%
Pharmacokinetics
8%
Placebo
8%
Human Monoclonal Antibody
8%
Disease Severity
8%
